EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

SIRT6 : A potential therapeutic target for diabetic cardiomyopathy

Tao Wu iD, Yiwei Qu, Shengjie Xu, Yong Wang, Xue Liu, Dufang Ma

The FASEB Journal · 2023

DOI: 10.1096/fj.202301012r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, 2023. Verfasst von Tao Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Sirtuins, Diabetes Mellitus. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The abnormal lipid metabolism in diabetic cardiomyopathy can cause myocardial mitochondrial dysfunction, lipotoxicity, abnormal death of myocardial cells, and myocardial remodeling. Mitochondrial homeostasis and normal lipid metabolism can effectively slow down the development of diabetic cardiomyopathy. Recent studies have shown that SIRT6 may play an important role in the pathological changes of diabetic cardiomyopathy such as myocardial cell death, myocardial hypertrophy, and myocardial fibrosis by regulating mitochondrial oxidative stress and glucose and lipid metabolism. Therefore, understanding the function of SIRT6 and its role in the pathogenesis of diabetic cardiomyopathy is of great significance for exploring and developing new targets and drugs for the treatment of diabetic cardiomyopathy. This article reviews the latest findings of SIRT6 in the pathogenesis of diabetic cardiomyopathy, focusing on the regulation of mitochondria and lipid metabolism by SIRT6 to explore potential clinical treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesSirtuinsDiabetes MellitusHumansMyocardiumMyocytes, CardiacMitochondria

Substanzen

SirtuinsSIRT6 protein, human

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of Cardiology, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China.

ORCID-Profile: Tao Wu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, T., Qu, Y., Xu, S., Wang, Y., Liu, X., & Ma, D. (2023). SIRT6 : A potential therapeutic target for diabetic cardiomyopathy. The FASEB Journal. https://doi.org/10.1096/fj.202301012r

Vancouver

Wu T, Qu Y, Xu S, Wang Y, Liu X, Ma D. SIRT6 : A potential therapeutic target for diabetic cardiomyopathy. The FASEB Journal. 2023. doi:10.1096/fj.202301012r

BibTeX
@article{Wu2023,
  author = {Wu, Tao and Qu, Yiwei and Xu, Shengjie and Wang, Yong and Liu, Xue and Ma, Dufang},
  title = {SIRT6 : A potential therapeutic target for diabetic cardiomyopathy},
  journal = {The FASEB Journal},
  year = {2023},
  doi = {10.1096/fj.202301012r}
}
Kostenlos starten →